Back to Search
Start Over
Signaling events initiated by kappa opioid receptor activation: quantification and immunocolocalization using phospho-selective KOR, p38 MAPK, and K(IR) 3.1 antibodies.
- Source :
-
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2011; Vol. 717, pp. 197-219. - Publication Year :
- 2011
-
Abstract
- Psychiatric disorders including anxiety, depression, and addiction are both precipitated and exacerbated by severe or chronic stress exposure. While acutely, stress responses are adaptive, repeated exposure to stress can dysregulate the brain in such a way as to predispose the organism to both physiological and mental illness. Understanding the neuronal chemicals, cell types, and circuits involved in both normal and pathological stress responses are essential in developing new therapeutics for psychiatric diseases. Varying degrees of stressor exposure cause the release of a constellation of chemicals, including neuropeptides such as dynorphin. Neuropeptidergic release can be very difficult to directly measure with adequate spatial and temporal resolution. Moreover, the downstream consequences following release and receptor binding are numerous and also difficult to measure with cellular resolution. Following repeated stressor exposure, dynorphin is released, binds to the kappa opioid receptor (KOR), and causes activation of KOR. Agonist-activated KOR becomes a substrate for G protein receptor kinase (GRK), which phosphorylates the Ser369 residue at the C-terminal tail of the receptor in the first step in the β-Arrestin-dependent desensitization cascade. Through the use of phospho--selective antibodies developed and validated in the laboratory, we have the tools, to assess with fine cellular resolution, the strength of behavioral stimulus required for release, time course of the release, and regional location of release. We have gone on to show that following KOR activation, both ERK 1/2 and p38 MAP kinase phosphorylation are increased through use of commercially available phospho-selective antibodies. Finally, we have identified that one effector of KOR/p38MAP kinase is K(IR) 3.1 and have developed a phospho-selective antibody against the Y12 motif of this channel. Much like KOR and p38 MAP kinase, phosphorylation of this potassium channel increases following repeated stress. The following chapter discusses immunohistochemical and quantification methods used for phospho-selective antibodies used in various brain regions following behavioral manipulations.
- Subjects :
- Animals
Antibodies, Phospho-Specific immunology
Antibodies, Phospho-Specific isolation & purification
Brain metabolism
Brain ultrastructure
Cell Line
Chromatography, Affinity methods
Humans
Mice
Microscopy methods
Mitogen-Activated Protein Kinase 1 analysis
Mitogen-Activated Protein Kinase 1 immunology
Mitogen-Activated Protein Kinase 1 metabolism
Mitogen-Activated Protein Kinase 3 analysis
Mitogen-Activated Protein Kinase 3 immunology
Mitogen-Activated Protein Kinase 3 metabolism
Potassium Channels, Inwardly Rectifying analysis
Potassium Channels, Inwardly Rectifying immunology
Rats
Receptors, Opioid, kappa analysis
Receptors, Opioid, kappa immunology
p38 Mitogen-Activated Protein Kinases analysis
p38 Mitogen-Activated Protein Kinases immunology
Antibodies, Phospho-Specific analysis
Immunohistochemistry methods
Potassium Channels, Inwardly Rectifying metabolism
Receptors, Opioid, kappa agonists
Receptors, Opioid, kappa metabolism
Signal Transduction
p38 Mitogen-Activated Protein Kinases metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1940-6029
- Volume :
- 717
- Database :
- MEDLINE
- Journal :
- Methods in molecular biology (Clifton, N.J.)
- Publication Type :
- Academic Journal
- Accession number :
- 21370032
- Full Text :
- https://doi.org/10.1007/978-1-61779-024-9_11